How much revenue did Vita 34 generate this year?
Vita 34 has achieved a revenue of 79.89 M EUR this year.
Vita 34 Revenue 2024
Vita 34 Revenue
79.89 M EUR
Vita 34 Dividend yield
3.11 %
Ticker
V3V.DE
ISIN
DE000A0BL849
WKN
A0BL84
In 2024, Vita 34's sales reached 79.89 M EUR, a 2.99% difference from the 77.57 M EUR sales recorded in the previous year.
The Vita 34 Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2027e | 128.03 | 13,98 |
| 2026e | 112.31 | 15,94 |
| 2025e | 82.32 | 21,75 |
| 2024e | 79.89 | 22,41 |
| 2023e | 77.57 | 23,08 |
| 2022 | 68.94 | 25,97 |
| 2021 | 28.42 | 43,77 |
| 2020 | 19.67 | 57,22 |
| 2019 | 19.93 | 59,11 |
| 2018 | 20.41 | 58,67 |
| 2017 | 19.19 | 56,28 |
| 2016 | 16.29 | 52,92 |
| 2015 | 14.17 | 45,79 |
| 2014 | 13.79 | 57,12 |
| 2013 | 13.55 | 59,48 |
| 2012 | 13.6 | 59,12 |
| 2011 | 16 | 59,13 |
| 2010 | 16.96 | 63,80 |
| 2009 | 15.1 | 67,15 |
| 2008 | 14.96 | 65,57 |
| 2007 | 15.43 | 67,34 |
| 2006 | 11.56 | 68,34 |
| 2005 | 10.23 | 66,76 |
Vita 34 Aktienanalyse
What does Vita 34 do?
Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Vita 34's Sales Figures
The sales figures of Vita 34 originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Vita 34’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Vita 34's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Vita 34’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Vita 34 Stock
How much was the turnover of the company Vita 34 compared to the previous year?
The revenue of Vita 34 has increased by 2.99% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Vita 34?
The revenue of Vita 34 is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Vita 34 measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Vita 34 so important for investors?
The revenue of Vita 34 is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Vita 34 pay?
Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.11 %. For the coming 12 months, Vita 34 is expected to pay a dividend of 0 EUR.
What is the dividend yield of Vita 34?
The current dividend yield of Vita 34 is 3.11 %.
When does Vita 34 pay dividends?
Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.
How secure is the dividend of Vita 34?
Vita 34 paid dividends every year for the past 0 years.
What is the dividend of Vita 34?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vita 34 located?
Vita 34 is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.
When did Vita 34 pay the last dividend?
The last dividend was paid out on 6/7/2019.
What was the dividend of Vita 34 in the year 2023?
In the year 2023, Vita 34 distributed 0 EUR as dividends.
In which currency does Vita 34 pay out the dividend?
The dividends of Vita 34 are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Vita 34 stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Vita 34
Our stock analysis for Vita 34 Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vita 34 Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
